Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out

ROBUST SOLUTION FOR DOWNSTREAM PROCESSING OF BIOTHERAPEUTICS

VIEWS: 19 PAGES: 3

Protein A gained significant popularity among the producers of biotherapeutics due to its universal binding capacity. The high price of such affinity media precludes their adaptation to a single-use environment. Upfront's mixed mode ligand Rhobust MAbDirect MM provides an alternative to Protein A that helps to address these challenges. Experimental tests were conducted by Upfront Chromatography and DSM Biologies to determine the performance of the ligand during crude feedstock processing.

More Info
  • pg 1
									strap goes here
purification
www.pharma-mag.com




robust soLution for DoWnstream
ProCessing of biotHeraPeutiCs
Faced with tremendous cost pressures, the biomanufacturing in
								
To top